Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders

NCT02156115 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT02156115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02156115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Terminated
Start date
March 23, 2015
Completion date
April 1, 2024
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphangiectasia, lymphangiomatosis, lymphedema, pulmonary lymphangiectasia